A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis

Area of Science:

• Molecular Biology
• Cancer Research
• Toxicology

Background:

• Arsenic is a known human carcinogen, but its liver cancer mechanisms remain unclear.
• The role of long non-coding RNAs (lncRNAs) in arsenic-induced liver carcinogenesis is unknown.
• Hepatocellular carcinoma (HCC) is a major health concern globally.

Purpose of the Study:

• To investigate the role of MALAT1 (a lncRNA) in arsenic-induced liver carcinogenesis.
• To explore the relationship between MALAT1, hypoxia-inducible factor (HIF)-2α, and malignant transformation.
• To elucidate the molecular mechanisms underlying arsenic's carcinogenic potential in the liver.

Main Methods:

• Analysis of MALAT1 and HIF-2α expression in human HCC tissues and sera from arsenite-exposed individuals.
• In vitro studies using human hepatic cells (L-02) treated with arsenite.
• In vivo studies using mouse xenograft models.

Main Results:

• MALAT1 and HIF-2α are over-expressed in HCC and correlate with clinicopathological features.
• Arsenite exposure induces MALAT1 and HIF-2α in hepatic cells, promoting malignant transformation.
• A positive feedback loop between MALAT1 and HIF-2α, involving VHL protein, drives arsenite-induced carcinogenesis.
• MALAT1 and HIF-2α enhance cell invasion, metastasis, and tumor growth in vitro and in vivo.
• Arsenite induces inflammation, MALAT1, and HIF-2α overexpression in mice.

Conclusions:

• The MALAT1/HIF-2α feedback loop is a key mechanism in arsenite-induced liver carcinogenesis.
• This study reveals a novel pathway involving reciprocal regulation of MALAT1 and HIF-2α.
• Findings expand the understanding of arsenic's carcinogenic mechanisms and potential therapeutic targets.